Home > Financial Ratios > SUN PHARMACEUTICAL INDUSTRIES

SUN PHARMACEUTICAL INDUSTRIES
EV/Core EBITDA

    Back to All Ratios
SUN PHARMACEUTICAL INDUSTRIES is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
COMMUNITY POLL
for SUN PHARMACEUTICAL INDUSTRIES
Please provide your vote to see the results

SUN PHARMACEUTICAL INDUSTRIES Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 23.6126.5119.2419.0315.10

What is the latest EV/Core EBITDA ratio of SUN PHARMACEUTICAL INDUSTRIES ?

The latest EV/Core EBITDA ratio of SUN PHARMACEUTICAL INDUSTRIES is 23.61 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar202523.61
Mar202426.51
Mar202319.24
Mar202219.03
Mar202115.10

How is EV/Core EBITDA of SUN PHARMACEUTICAL INDUSTRIES Trending?

Years EV/Core EBITDA % Change
Mar2025 23.61
-10.94
Mar2024 26.51
37.79
Mar2023 19.24
1.10
Mar2022 19.03
26.03
Mar2021 15.1 -

Other Financial Ratios of SUN PHARMACEUTICAL INDUSTRIES


Compare EV/Core EBITDA ratio of peers of SUN PHARMACEUTICAL INDUSTRIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SUN PHARMACEUTICAL INDUSTRIES ₹433,613.5 Cr 0.6% -2.8% 6.2% Stock Analytics
DIVIS LABORATORIES ₹176,087.0 Cr 0.4% 0.1% 0.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹154,837.0 Cr 3.4% 4.3% 42% Stock Analytics
CIPLA ₹112,194.0 Cr -1.3% 7% -7.6% Stock Analytics
DR REDDYS LABORATORIES ₹106,328.0 Cr -0.2% 0.4% -1.4% Stock Analytics
MANKIND PHARMA ₹98,270.3 Cr 1.5% -0.2% 0.4% Stock Analytics


SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SUN PHARMACEUTICAL INDUSTRIES

0.6%

-2.8%

6.2%

SENSEX

1.7%

1.3%

-7.3%


You may also like the below Video Courses